LISA LEFANTY: Open Payments
NPI 1588389894 · PLACERVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 12 payments from 9 companies in 2025. Trend: 2023 $1,285 · 2024 $559 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $241 |
| Solta Medical, a division of Bausch Health US, LLC | 3 | $150 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $121 |
| PFIZER INC. | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $120 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Vanda Pharmaceuticals Inc. | 1 | $106 |
| Tandem Diabetes Care, Inc. | 1 | $73 |
Products named: TEZSPIRE, SPRAVATO, NURTEC ODT, Epclusa, Ozempic, FANAPT, CLEAR+BRILLIANT, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across CA — which companies pay providers there.
